JPH06500730A - 改良された接線フロー濾過法および装置 - Google Patents
改良された接線フロー濾過法および装置Info
- Publication number
- JPH06500730A JPH06500730A JP3515683A JP51568391A JPH06500730A JP H06500730 A JPH06500730 A JP H06500730A JP 3515683 A JP3515683 A JP 3515683A JP 51568391 A JP51568391 A JP 51568391A JP H06500730 A JPH06500730 A JP H06500730A
- Authority
- JP
- Japan
- Prior art keywords
- filtration
- membrane
- filtrate
- chamber
- species
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 110
- 238000009295 crossflow filtration Methods 0.000 title claims description 51
- 238000001914 filtration Methods 0.000 claims description 281
- 239000012528 membrane Substances 0.000 claims description 192
- 239000000706 filtrate Substances 0.000 claims description 150
- 241000894007 species Species 0.000 claims description 72
- 239000011148 porous material Substances 0.000 claims description 61
- 238000000108 ultra-filtration Methods 0.000 claims description 59
- 239000000203 mixture Substances 0.000 claims description 55
- 239000007788 liquid Substances 0.000 claims description 51
- 230000008569 process Effects 0.000 claims description 30
- 230000007704 transition Effects 0.000 claims description 29
- 239000012530 fluid Substances 0.000 claims description 26
- 238000000926 separation method Methods 0.000 claims description 25
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 12
- 230000003134 recirculating effect Effects 0.000 claims description 10
- 238000001471 micro-filtration Methods 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 239000002158 endotoxin Substances 0.000 claims description 4
- 210000004962 mammalian cell Anatomy 0.000 claims description 4
- 241000204031 Mycoplasma Species 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000012465 retentate Substances 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims 3
- 230000003247 decreasing effect Effects 0.000 claims 3
- 238000012360 testing method Methods 0.000 description 49
- 108010052832 Cytochromes Proteins 0.000 description 34
- 102000018832 Cytochromes Human genes 0.000 description 34
- 238000000746 purification Methods 0.000 description 20
- 238000011032 high-performance TFF Methods 0.000 description 17
- 238000005086 pumping Methods 0.000 description 16
- 230000014759 maintenance of location Effects 0.000 description 15
- 230000000717 retained effect Effects 0.000 description 15
- 210000002381 plasma Anatomy 0.000 description 14
- 238000011160 research Methods 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 description 11
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 description 11
- 230000010287 polarization Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 239000004627 regenerated cellulose Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000010408 film Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 238000001223 reverse osmosis Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008364 bulk solution Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- CCTIOCVIZPCTGO-BYPYZUCNSA-N phosphoarginine Chemical compound OC(=O)[C@@H](N)CCCNC(=N)NP(O)(O)=O CCTIOCVIZPCTGO-BYPYZUCNSA-N 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 108010007529 Cytochromes c2 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 238000006957 Michael reaction Methods 0.000 description 1
- 101710112672 Probable tape measure protein Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101710204224 Tape measure protein Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000011072 cell harvest Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 108010018850 cytochrome C(551) Proteins 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/58—Reaction vessels connected in series or in parallel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/10—Separation or concentration of fermentation products
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Water Supply & Treatment (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Cyclones (AREA)
- Combined Means For Separation Of Solids (AREA)
Abstract
Description
Claims (46)
- 1.混合物から所望の種を分離する方法であって、流動率を転移点流動率の約5 から100%の範囲のレベルに維持しながら、混合物から所望の種を分離する孔 径を有する膜による接線フロー濾過により混合物を濾過することを特徴とする方 法。
- 2.濾過の転移点においてのトランスメンブラン圧を膜に添って実質的にトラン スメンブラン圧より低いレベルで一定に保つ請求項1に記載の方法。
- 3.膜が同じ孔径を有する平行に積層された複数の膜からなる請求項1に記載の 方法。
- 4.膜が同じ孔径の2つの膜からなる請求項3に記載の方法。
- 5.所望の種のサイズが最高約10ミクロンである請求項1に記載の方法。
- 6.流動率が転移点流動率の約50〜100%である請求項1に記載の方法。
- 7.流動率が転移点流動率の約75〜100%である請求項1に記載の方法。
- 8.種が、微生物、哺乳動物細胞、蛋白質、ポリペプチド、アミノ酸、コロイド 、マイコプラズマ、エンドトキシン、ウイルス、炭水化物、RNAおよびDNA からなる群より選択される生物学的物質である請求項1に記載の方法。
- 9.混合物が希釈されない請求項1に記載の方法。
- 10.所望の種の分子量が混合物の他の種より10倍未満大きいかまたは小さい 請求項1に記載の方法。
- 11.濾過の保留物を、分離しようとする混合物を入れたタンクに再循環させ、 このプロセスを繰り返す請求項1に記載の方法。
- 12.更に、第二接線フロー濾過段階において濾過からの濾液を第一濾過段階で 用いた膜より小さな孔径を有する膜を通して濾過し、この第二濾過段階の濾液を 第一濾過段階に戻し、このプロセスを繰り返すことからなる多段階である請求項 1に記載の方法。
- 13.第二濾過段階の流動率が転移点流動率の約100%より大きい請求項12 に記載の方法。
- 14.両濾過段階が限外濾過である請求項13に記載の方法。
- 15.更に、第二濾過段階からの濾液を第三接線フロー濾過段階において、第二 膜より小さな孔径を有する濾過膜を通して濾過し、第三濾過段階から得られた濾 液を第一濾過段階に戻し、このプロセスを繰り返すことからなる請求項12に記 載の方法。
- 16.第三濾過段階の流動率が転移点流動率の約100%より大きい請求項15 に記載の方法。
- 17.3つの濾過段階がすべて限外濾過である請求項16に記載の方法。
- 18.濾過の進行とともにトランスメンプラン圧を減少させる請求項1に記載の 方法。
- 19.トランスメンブラン圧が濾過の進行に伴いほぼ一定に保たれる請求項1に 記載の方法。
- 20.分子量が約1から1000kDaである所望の種を混合物から分離する方 法であって、流動率を転移点流動率の約5〜100%の範囲のレベルに維持しな がら、該所望の種を混合物から分離する孔径を有する濾過膜による接線フロー濾 過により混合物を濾過することからなり、それにより所望の種を選択的に混合物 から分離する方法。
- 21.所望の種が、蛋白質、ポリペプチド、アミノ酸、コロイド、マイコプラズ マ、エンドトキシン、ウイルス、炭水化物、RNAおよびDNAからなる群から 選択される生物学的物質である請求項20に記載の方法。
- 22.所望の種が蛋白質またはポリペプチドである請求項21に記載の方法。
- 23.所望の種の分子量が混合物の他の種より10倍未満大きいかまたは小さい 請求項20に記載の方法。
- 24.トランスメンプラン圧が、濾過の転移点でのトランスメンプラン圧より低 いレベルで膜に添って実質的に一定に保たれる請求項20に記載の方法。
- 25.更に、第二接線フロー濾過段階において、濾液を第一濾過段階の膜より小 さな孔径を有する限外濾過膜を通して濾過し、この濾液を第一濾過段階に戻し、 このプロセスを繰り返すことからなる請求項20に記載の方法。
- 26.第二濾過段階からの濾液を第三接線フロー濾過段階において、第二膜より 小さな孔径を有する限外濾過膜を通して濾過し、第三濾過段階から得られた濾液 を第一限外濾過段階に再循環させ、このプロセスを繰り返すことからなる請求項 25に記載の方法。
- 27.大きさが約0.1〜10ミクロンである所望の種を混合物から分離する方 法であって、流動率を転移点流動率の約5〜100%の範囲のレベルに維持しな がら、該所望の種を混合物から分離する孔径を有する濾過膜による接線フロー濾 過により混合物を濾過することからなり、それにより所望の種を混合物から選択 的に分離する方法。
- 28.トランスメンプラン圧が、濾過の転移点でのトランスメンプラン圧より低 いレベルで膜に添って実質的に一定に保たれる請求項27に記載の方法。
- 29.所望の種が、哺乳動物細胞または微生物である請求項27に記載の方法。
- 30.所望の種の大きさが混合物の他の種より10倍未満大きいかまたは小さい 請求項27に記載の方法。
- 31.(a)濾過ユニットをそれぞれ入口および出口を有する濾過および濾液室 に隔てる、複数の同一孔径を有する隣接した平行な濾過膜を含む濾過ユニットと 液体連絡している液体容器; (b)液体を容器から該濾過室の入口に送り出す手段を含む、濾過室の入口を容 器に接続する手段; (c)濾液室内に圧力勾配を発生させる手段;および(d)該濾液室の出口から 濾液を集める手段;からなる接線フロー濾過装置。
- 32.2枚の膜を含む請求項31に記載の装置。
- 33.発生手段が濾液を濾過室の液体の方向に平行な濾液室を通して再循環させ る手段である請求項31に記載の装置。
- 34.再循環手段がポンプであり、収集手段が第二容器である請求項33に記載 の装置。
- 35.膜が、約1〜1000kDaの範囲の分子量を有する種を保持する孔径を 有する限外濾過装置である請求項31に記載の装置。
- 36.膜が、約0.1〜10ミクロンの範囲の大きさを有する種を保持する孔径 を有する精密濾過装置である請求項31に記載の装置。
- 37.複数の積層された濾過および濾液室を有する濾過ユニットを含有する接線 フロー濾過装置であって、積層順で最後の濾液室以外はすべて別の容器と液体連 絡している入口および出口手段を有し、最後の濾液室は積層順での第一濾液室に 液体連絡している容器に濾液を循環させるための出口手段を有し、各室は容器か ら液体を室の入口手段に送り出す手段を有し、各室は濾過膜により隣接する室か ら隔てられており、 全室の入口手段から出口手段への液体の流れが平行かつ同一方向であり、積層順 で最初の濾過膜は最大サイズの種を保持する孔径を有し、積層順で最後の濾過膜 は最小サイズの種を保持する孔径を有し、積層順で中間の濾過膜は中間層膜の最 初から最後へと大きさが減少するサイズの種を保持する孔径を有する装置。
- 38.各濾過膜が複数の同一孔径を有する平行して隣接する膜からなる請求項3 7に記載の装置。
- 39.各膜が2枚の同一孔径を有する平行して隣接する膜からなる請求項38に 記載の装置。
- 40.濾過ユニットが3室および2容器からなる請求項37に記載の装置。
- 41.濾過ユニットが4室および3容器からなる請求項37に記載の装置。
- 42.(a)第一濾過ユニットをそれぞれ入口および出口を有する第一の濾過お よび濾液室に隔てる、第一濾過膜を有する第一濾過ユニットと液体連絡している 第一容器; (b)液体を第一容器から第一濾過室の入口に送り出す手段を含む、第一濾過室 の入口を第一容器に接続する手段; (c)第一濾液室内に圧力勾配を発生させる手段;(d)第二濾過ユニットをそ れぞれ入口および出口を有する第二の濾過および濾液室に隔てる、第二濾過膜を 有する第二濾過ユニットと液体連絡している第二容器; (e)濾液を第一濾液室の出口から第二容器に循環させる手段;(f)液体を第 二容器から第二濾過室の入口に送り出す手段を含む、第二濾過室の入口を第二容 器に接続する手段; (g)第二濾液室内に圧力勾配を発生させる手段;(h)第三濾過ユニットをそ れぞれ入口および出口を有する第三の濾過および濾液室に隔てる、第三濾過膜を 有する第三濾過ユニットと液体連絡している第三容器; (i)濾液を第二濾液室の出口から第三容器に循環させる手段;(j)液体を第 三容器から第三濾過室の入口に送り出す手段を含む、第三濾過室の入口を第三容 器に接続する手段;および(k)濾液を第三濾液室の出口から第一容器に循環さ せるための手段;を含有する接線フロー濾過装置であって、第一濾過膜が最大サ イズの種を保持する孔径を有し、第二濾過膜が第一および第三濾過膜の孔径の中 間のサイズの種を保持し、そして第三濾過膜が最小サイズの種を保持する孔径を 有する接線フロー濾過装置。
- 43.第三濾液室内に圧力勾配を発生させる手段を更に含む請求項42に記載の 装置。
- 44.すべての発生手段が濾液を濾過室内の液体の方向に平行な濾液室を通して 再循環させるための手段である請求項42に記載の装置。
- 45.再循環手段がポンプである請求項44に記載の装置。
- 46.膜がカスケードにおいて孔径が減少する限外濾過膜である請求項42に記 載の装置。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US583,886 | 1990-09-17 | ||
| US07/583,886 US5256294A (en) | 1990-09-17 | 1990-09-17 | Tangential flow filtration process and apparatus |
| PCT/US1991/006553 WO1992004970A1 (en) | 1990-09-17 | 1991-09-11 | Improved tangential filtration process and apparatus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003156060A Division JP2003334425A (ja) | 1990-09-17 | 2003-05-30 | 改良された接線フロー濾過法および装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06500730A true JPH06500730A (ja) | 1994-01-27 |
| JP3828143B2 JP3828143B2 (ja) | 2006-10-04 |
Family
ID=24334996
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51568391A Expired - Lifetime JP3828143B2 (ja) | 1990-09-17 | 1991-09-11 | 改良された接線フロー濾過法および装置 |
| JP2003156060A Withdrawn JP2003334425A (ja) | 1990-09-17 | 2003-05-30 | 改良された接線フロー濾過法および装置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003156060A Withdrawn JP2003334425A (ja) | 1990-09-17 | 2003-05-30 | 改良された接線フロー濾過法および装置 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5256294A (ja) |
| EP (1) | EP0552192B1 (ja) |
| JP (2) | JP3828143B2 (ja) |
| AT (1) | ATE119063T1 (ja) |
| CA (1) | CA2089663C (ja) |
| DE (1) | DE69107855T2 (ja) |
| DK (1) | DK0552192T3 (ja) |
| ES (1) | ES2072017T3 (ja) |
| LV (1) | LV11283B (ja) |
| WO (1) | WO1992004970A1 (ja) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001000842A (ja) * | 1998-05-22 | 2001-01-09 | Daicel Chem Ind Ltd | 病原性原虫濃縮用モジュールおよび濃縮方法 |
| JP2003503041A (ja) * | 1999-06-25 | 2003-01-28 | アメリカン・サイアナミド・カンパニー | 内在性膜タンパク質の抽出 |
| JP2008514237A (ja) * | 2004-09-30 | 2008-05-08 | バイヤー ヘルスケア エルエルシー | 生体分子の一貫連続製造のための装置及び方法 |
| JP2022524915A (ja) * | 2019-01-25 | 2022-05-11 | ベクトン・ディキンソン・アンド・カンパニー | 生体サンプルから構成成分を選択的に抽出する方法および機器 |
Families Citing this family (124)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256294A (en) * | 1990-09-17 | 1993-10-26 | Genentech, Inc. | Tangential flow filtration process and apparatus |
| DE4139664A1 (de) * | 1991-12-02 | 1993-06-03 | Diagen Inst Molekularbio | Vorrichtung und verfahren zur isolierung und reinigung von nukleinsaeuren |
| FR2693474B1 (fr) * | 1992-07-09 | 1994-08-26 | Daniel Garin | Procédé et dispositif de séparation et de concentration de microorganismes contaminants. |
| US5705634A (en) * | 1995-03-02 | 1998-01-06 | Perimmune Holdings, Inc. | High yield preparation of dimeric to decameric chitin oligomers |
| US6359114B1 (en) | 1995-06-07 | 2002-03-19 | Aphton Corp. | System for method for the modification and purification of proteins |
| US6165774A (en) * | 1995-09-22 | 2000-12-26 | Connaught Laboratories Limited | Parainfluenza virus glycoproteins and vaccines |
| US6054051A (en) * | 1996-01-17 | 2000-04-25 | Genentech, Inc. | Tangential-flow filtration system |
| US6268487B1 (en) * | 1996-05-13 | 2001-07-31 | Genzyme Transgenics Corporation | Purification of biologically active peptides from milk |
| FR2749191B1 (fr) * | 1996-06-04 | 1998-07-17 | Rhone Poulenc Fibres | Procede de filtration d'un melange reactionnel triphasique |
| US7026468B2 (en) * | 1996-07-19 | 2006-04-11 | Valentis, Inc. | Process and equipment for plasmid purification |
| US7807822B2 (en) * | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
| US6022333A (en) * | 1997-05-01 | 2000-02-08 | S.L.I.M. Tech, Ltd. | Method and system for removing materials from lymphatic and other fluids |
| US5919376A (en) * | 1997-06-10 | 1999-07-06 | Cae Ransohoff Inc. | Filtration apparatus and method |
| US6265542B1 (en) | 1997-10-24 | 2001-07-24 | Genentech, Inc. | Purification of molecules |
| US6077940A (en) | 1997-12-24 | 2000-06-20 | Genentech, Inc. | Free solution ligand interaction molecular separation method |
| EP1500661A1 (en) * | 1998-06-01 | 2005-01-26 | Genetech, Inc. | Separation of protein monomers from aggregates by use of ion-exchange chromatography |
| BR9905868A (pt) * | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento |
| US7316780B1 (en) * | 1999-01-29 | 2008-01-08 | Pall Corporation | Range separation devices and processes |
| CA2378944A1 (en) | 1999-07-23 | 2001-02-01 | Genentech, Inc. | Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration |
| US7108791B2 (en) * | 1999-09-14 | 2006-09-19 | Millipore Corporation | High-resolution virus removal methodology and filtration capsule useful therefor |
| US6296770B1 (en) | 1999-12-09 | 2001-10-02 | Eastman Kodak Company | Constant concentration at the UF membrane wall UF process control and apparatus |
| DE10000196B4 (de) * | 2000-01-05 | 2013-10-10 | Sartorius Stedim Biotech Gmbh | Verbesserte Crossflow-Filtrationseinheit |
| US6607669B2 (en) * | 2000-06-23 | 2003-08-19 | Scilog, Inc. | Method and apparatus for enhancing filtration yields in tangential flow filtration |
| GB0107634D0 (en) * | 2001-03-27 | 2001-05-16 | Fermentas Ab | Nucleic acid purification |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| US20030171260A1 (en) * | 2002-03-11 | 2003-09-11 | Nelson Deanna Jean | Compositions and methods utilizing hydroxamates to scavenge oxidant toxins |
| WO2003102132A2 (en) | 2002-04-26 | 2003-12-11 | Genetech, Inc. | Non-affinity purification of proteins |
| US9283521B2 (en) | 2002-06-14 | 2016-03-15 | Parker-Hannifin Corporation | Single-use manifold and sensors for automated, aseptic transfer of solutions in bioprocessing applications |
| US6712963B2 (en) * | 2002-06-14 | 2004-03-30 | Scilog, Llc | Single-use manifold for automated, aseptic transfer of solutions in bioprocessing applications |
| USRE49221E1 (en) | 2002-06-14 | 2022-09-27 | Parker Intangibles, Llc | Single-use manifolds for automated, aseptic handling of solutions in bioprocessing applications |
| CN1713951B (zh) * | 2002-06-19 | 2010-05-26 | 西北生物治疗药物公司 | 切向流过滤设备和白细胞富集方法 |
| AU2003248780A1 (en) * | 2002-07-10 | 2004-01-23 | Pall Corporation | Hollow fiber membrane systems |
| US7314746B2 (en) | 2002-09-13 | 2008-01-01 | Valentis, Inc. | Apparatus and method for preparative scale purification of nucleic acids |
| AU2003261387A1 (en) * | 2003-02-24 | 2004-09-17 | Gtc Biotherapeutics, Inc. | Methods of tangential flow filtration and an apparatus therefore |
| US7276163B2 (en) * | 2003-10-01 | 2007-10-02 | Ceramem Corporation | Membrane devices with controlled transmembrane pressure and method of use |
| CA2553234C (en) * | 2004-01-21 | 2012-07-24 | Toray Industries, Inc. | Fractionator and method of fractionation |
| FR2866899B1 (fr) * | 2004-02-27 | 2006-06-09 | Gervais Danone Sa | Procede de production d'un concentrat liquide de bacteries adaptees et viables a usage alimentaire |
| US20050197496A1 (en) * | 2004-03-04 | 2005-09-08 | Gtc Biotherapeutics, Inc. | Methods of protein fractionation using high performance tangential flow filtration |
| CA2557046A1 (en) | 2004-03-05 | 2005-10-13 | John Crowley | Process for cell culturing by continuous perfusion and alternating tangential flow |
| WO2005094963A1 (en) * | 2004-03-29 | 2005-10-13 | Pall Corporation | Pleated, crossflow fluid treatment elements |
| WO2005113578A1 (en) * | 2004-05-14 | 2005-12-01 | New Jersey Institute Of Technology | Highly selective membrane systems and methods for protein ultrafiltration |
| EP1753999B1 (fr) * | 2004-05-28 | 2013-11-20 | Alstom Technology Ltd | Dispositif a lit fluidise a agent comburant enrichi en oxygene |
| US20060043021A1 (en) | 2004-09-02 | 2006-03-02 | Millipore Corporation | Port adapter for tangential flow filtration |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| AU2011203578B2 (en) * | 2004-09-30 | 2012-10-11 | Bayer Healthcare Llc | Devices and methods for integrated continuous manufacturing of biological molecules |
| US20060130159A1 (en) * | 2004-12-09 | 2006-06-15 | Nick Masiello | Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum |
| CA3000520C (en) | 2005-08-24 | 2023-04-04 | Immunogen, Inc. | Process for preparing antibody maytansinoid conjugates |
| WO2007038542A2 (en) * | 2005-09-28 | 2007-04-05 | Pall Corporation | Fluid treatment assemblies and elements and methods for making them |
| RU2008128451A (ru) * | 2005-12-14 | 2010-01-20 | Огенодженесис, Инк. (US) | Композиция для лечения и ухода за кожей, способ ее получения, способ ее использования |
| US7384549B2 (en) | 2005-12-29 | 2008-06-10 | Spf Innovations, Llc | Method and apparatus for the filtration of biological solutions |
| US7531632B2 (en) * | 2006-02-16 | 2009-05-12 | Gtc Biotherapeutics, Inc. | Clarification of transgenic milk using depth filtration |
| AU2007218753B2 (en) | 2006-02-24 | 2012-08-16 | Toray Industries, Inc. | Method of producing chemical product and continuous fermentation apparatus |
| CN101415482B (zh) * | 2006-03-31 | 2015-04-15 | 金克克国际有限公司 | 用于化合物分离的切向流动过滤设备、系统和方法 |
| US20110094310A1 (en) * | 2006-04-12 | 2011-04-28 | Millipore Corporation | Filter with memory, communication and pressure sensor |
| US20070240578A1 (en) * | 2006-04-12 | 2007-10-18 | Dileo Anthony | Filter with memory, communication and temperature sensor |
| US8007568B2 (en) * | 2006-04-12 | 2011-08-30 | Millipore Corporation | Filter with memory, communication and pressure sensor |
| US20070243113A1 (en) * | 2006-04-12 | 2007-10-18 | Dileo Anthony | Filter with memory, communication and concentration sensor |
| KR101685246B1 (ko) | 2006-07-14 | 2016-12-09 | 디피엑스 홀딩스 비.브이. | 개선된 세포 배양 방법 |
| US20090250653A1 (en) | 2006-08-07 | 2009-10-08 | Kiely Donald E | Hydroxycarboxylic Acids and Salts |
| US7692041B2 (en) * | 2006-08-07 | 2010-04-06 | The University Of Montana | Method of oxidation using nitric acid |
| CN101269298B (zh) * | 2007-03-23 | 2011-06-01 | 中国科学院过程工程研究所 | 利用浓差极化浓缩生物大分子的膜过滤方法及其装置 |
| CN101754977B (zh) * | 2007-07-17 | 2013-07-17 | 弗·哈夫曼-拉罗切有限公司 | 可变切向流过滤 |
| DK2641652T3 (en) | 2007-09-12 | 2019-04-29 | Danisco Us Inc | FILTERING WITH INTERNAL POLLUTION CONTROL |
| US8623943B2 (en) | 2007-11-15 | 2014-01-07 | The University Of Montana | Hydroxypolyamide gel forming agents |
| US20100249384A1 (en) * | 2007-11-29 | 2010-09-30 | Stefan Hepbildikler | Immunoglobulin aggregates |
| US8043512B2 (en) * | 2008-04-11 | 2011-10-25 | Pall Corporation | Fluid treatment arrangements and methods |
| US20090277824A1 (en) * | 2008-05-09 | 2009-11-12 | Sal Giglia | Method for reducing performance variability of multi-layer filters |
| US7895084B2 (en) * | 2008-05-15 | 2011-02-22 | Doapp, Inc. | Method and system for providing purchasing on a wireless device |
| US8216473B2 (en) * | 2008-06-13 | 2012-07-10 | Solution Dynamics, Llc | Apparatus and methods for solution processing using reverse osmosis |
| US8048315B2 (en) * | 2008-07-28 | 2011-11-01 | Pall Corporation | Fluid treatment arrangements and methods |
| US9320761B2 (en) * | 2008-12-18 | 2016-04-26 | Vivex Biomedical, Inc. | Bone induction system and methods |
| EP2411125B1 (en) * | 2009-03-24 | 2019-05-08 | Wyeth LLC | Membrane evaporation for generating highly concentrated protein therapeutics |
| CN102574912B (zh) * | 2009-09-29 | 2014-12-24 | 弗·哈夫曼-拉罗切有限公司 | 缓冲溶质的过滤前调节 |
| US8119005B1 (en) * | 2009-11-12 | 2012-02-21 | Gabriel George Pinter | Method and apparatus for partial desalination of a concentrated salt solution |
| CN101745316B (zh) * | 2010-01-22 | 2011-12-28 | 中国科学院过程工程研究所 | 一种重力场辅助浓缩生物大分子的新型超滤方法及装置 |
| EP2525899A1 (en) * | 2010-01-22 | 2012-11-28 | Lonza Walkersville, Inc. | High yield method and apparatus for volume reduction and washing of therapeutic cells using tangential flow filtration |
| NZ600657A (en) * | 2010-03-18 | 2014-01-31 | Gea Mechanical Equipment Gmbh | System and method for filtering beverages |
| US8480978B2 (en) * | 2010-08-12 | 2013-07-09 | University Of Southern California | Microfluidic fluid separator and related methods |
| US9404188B2 (en) | 2010-11-11 | 2016-08-02 | Rivertop Renewables | Corrosion inhibiting composition |
| JP2013544524A (ja) * | 2010-12-06 | 2013-12-19 | ターポン バイオシステムズ,インコーポレイテッド | 生物学的生成物の連続プロセス法 |
| CN103649290B (zh) | 2011-04-21 | 2015-08-05 | 里弗领袖可再生能源公司 | 钙螯合组合物 |
| AU2012274016B2 (en) * | 2011-12-13 | 2014-09-04 | Cytiva Us Llc | Membrane with localized asymmetries |
| US9266066B2 (en) * | 2011-12-13 | 2016-02-23 | Pall Corporation | Membrane with localized asymmetries |
| US10265388B2 (en) * | 2012-02-21 | 2019-04-23 | Cytonics Corporation | Systems, compositions, and methods for transplantation |
| EP2984467B1 (en) * | 2012-10-18 | 2020-10-14 | Innovaprep LLC | Liquid to liquid biological particle fractionation and concentration |
| CN104755489B (zh) | 2012-10-30 | 2019-01-15 | 弗·哈夫曼-拉罗切有限公司 | 使用双级切线流超滤纯化多肽 |
| EP2730330A1 (en) | 2012-11-09 | 2014-05-14 | Tine SA | Membrane filtration assembly and method of controlling trans-membrane pressure |
| CA2892939A1 (en) | 2012-11-28 | 2014-06-05 | Rivertop Renewables | Corrosion inhibiting, freezing point lowering compositions |
| CA2905808A1 (en) | 2013-03-13 | 2014-10-02 | Rivertop Renewables, Inc. | Improved nitric acid oxidation processes |
| US9346736B2 (en) | 2013-03-13 | 2016-05-24 | Rivertop Renewables, Inc. | Oxidation process |
| US9670124B2 (en) | 2013-03-13 | 2017-06-06 | Rivertop Renewables, Inc. | Nitric acid oxidation process |
| JP6586075B2 (ja) | 2013-03-14 | 2019-10-02 | トランスレイト バイオ, インコーポレイテッド | メッセンジャーrnaの精製方法 |
| EP2971165A4 (en) * | 2013-03-15 | 2016-11-23 | Moderna Therapeutics Inc | DISSOLUTION OF DNA FRAGMENTS IN MRNA MANUFACTURING METHODS |
| DK2970948T3 (en) | 2013-03-15 | 2019-04-08 | Glaxosmithkline Biologicals Sa | METHODS OF RNA PURIFICATION |
| EP3016729B1 (fr) | 2013-07-05 | 2020-03-25 | Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme | Matrice de chromatographie d'affinité |
| EP3113865A4 (en) * | 2014-03-07 | 2017-11-01 | Agency For Science, Technology And Research | Apparatus and methods for fractionation of biological products |
| WO2015153370A2 (en) | 2014-03-29 | 2015-10-08 | Labib Mohamed E | Blood processing cartridges and systems, and methods for extracorporeal blood therapies |
| US10324070B2 (en) * | 2014-04-23 | 2019-06-18 | Chromatan Inc. | High efficiency continuous countercurrent tangential chromatography |
| US9850269B2 (en) | 2014-04-25 | 2017-12-26 | Translate Bio, Inc. | Methods for purification of messenger RNA |
| EP4218991A1 (en) | 2014-05-13 | 2023-08-02 | Amgen Inc. | Process control systems and methods for use with filters and filtration processes |
| DE102015108501A1 (de) * | 2015-05-29 | 2016-12-01 | Sartorius Stedim Biotech Gmbh | Verfahren und Filtrationsvorrichtung zur Herstellung einer konzentrierten Produktlösung |
| EP4660315A3 (en) | 2015-05-29 | 2026-03-18 | CureVac Manufacturing GmbH | A method for producing and purifying rna, comprising at least one step of tangential flow filtration |
| US10426884B2 (en) | 2015-06-26 | 2019-10-01 | Novaflux Inc. | Cartridges and systems for outside-in flow in membrane-based therapies |
| EP3328522A4 (en) | 2015-07-29 | 2019-04-24 | Gradiant Corporation | OSMOTIC COLLECTION PROCESSES AND RELATED SYSTEMS |
| US11110398B2 (en) | 2015-08-20 | 2021-09-07 | Cytiva Sweden Ab | Method for enhancing filtration yields in tangential flow filtration system |
| US10399040B2 (en) | 2015-09-24 | 2019-09-03 | Novaflux Inc. | Cartridges and systems for membrane-based therapies |
| WO2017087897A1 (en) | 2015-11-18 | 2017-05-26 | Arytha Biosciences, Llc | Processes and systems for preparing cellular or viral membranes and nanoparticles |
| US10463767B2 (en) | 2016-04-22 | 2019-11-05 | Vivex Biologics Group, Inc. | Moldable bone composition |
| US9788950B1 (en) | 2016-04-22 | 2017-10-17 | Vivex Biomedical, Inc. | Cohesive bone composition |
| US11253629B2 (en) | 2016-04-22 | 2022-02-22 | Vivex Biologics Group, Inc. | Bone gel sheet composition and method of manufacture |
| US11253630B2 (en) | 2016-04-22 | 2022-02-22 | Vivex Biologics Group, Inc. | Malleable demineralized bone composition and method of manufacture |
| US10596298B2 (en) | 2016-04-22 | 2020-03-24 | Vivex Biologics Group, Inc. | Malleable demineralized bone composition and method of manufacture |
| WO2017223176A1 (en) | 2016-06-24 | 2017-12-28 | Modernatx, Inc. | Methods and apparatus for filtration |
| CN110241012B (zh) * | 2018-03-09 | 2022-11-01 | 嘉和生物药业有限公司 | 一种生物大分子上游分阶段截留的生产方法、生产模块及在生产中的应用 |
| MY206967A (en) | 2018-08-22 | 2025-01-22 | Gradiant Corp | Liquid solution concentration system comprising isolated subsystem and related methods |
| KR102950141B1 (ko) | 2018-08-24 | 2026-04-07 | 트랜슬레이트 바이오 인코포레이티드 | 전령 rna의 정제 방법 |
| DE102020119204A1 (de) * | 2020-07-21 | 2022-01-27 | BoSeVo GmbH | Vorrichtung zur Membranfiltration und zur Entfernung von Mikroschadstoffen mittels eines Reaktivstoffes aus Flüssigkeiten |
| ES1256540Y (es) * | 2020-07-30 | 2021-02-10 | Euromed S A | Composicion alimenticia en polvo que comprende eriocitrina |
| CN114249843A (zh) * | 2020-09-24 | 2022-03-29 | 九芝堂股份有限公司 | 一种使用切向流超滤纯化低分子量岩藻糖化糖胺聚糖的方法 |
| CN116406369A (zh) * | 2020-10-05 | 2023-07-07 | 百时美施贵宝公司 | 用于浓缩蛋白质的方法 |
| EP4247522A4 (en) | 2020-11-17 | 2024-10-09 | Gradiant Corporation | OSMOTIC SYSTEMS AND PROCESSES INVOLVING ENERGY HARVESTING |
| EP4243966A1 (en) | 2020-11-23 | 2023-09-20 | Abec, Inc. | Filtration systems,components and methods |
| CN121046364A (zh) | 2022-07-29 | 2025-12-02 | 赛诺菲巴斯德有限公司 | 用于无乙醇mRNA纯化的方法 |
| WO2025163146A1 (en) | 2024-01-31 | 2025-08-07 | Sanofi | Methods for ethanol-free mrna purification |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3744642A (en) * | 1970-12-30 | 1973-07-10 | Westinghouse Electric Corp | Interface condensation desalination membranes |
| SE396017B (sv) * | 1974-12-23 | 1977-09-05 | Alfa Laval Ab | Filtreringsforfarande, serskilt for ultrafiltrering |
| FR2380052A1 (fr) * | 1977-02-11 | 1978-09-08 | Akzo Nv | Membrane de dialyse pour l'hemodialyse |
| US4191182A (en) * | 1977-09-23 | 1980-03-04 | Hemotherapy Inc. | Method and apparatus for continuous plasmaphersis |
| JPS5681521A (en) * | 1979-12-10 | 1981-07-03 | Toyo Soda Mfg Co Ltd | Separation of blood serum and protein |
| US4350156A (en) * | 1980-05-29 | 1982-09-21 | Japan Foundation For Artificial Organs | Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid |
| US4746436A (en) * | 1981-06-25 | 1988-05-24 | Baxter Travenol Laboratories, Inc. | Membrane plasmapheresis apparatus and process which utilize a flexible wall to variably restrict the flow of plasma filtrate and thereby stabilize transmembrane pressure |
| NO158658C (no) * | 1981-07-01 | 1988-10-19 | Pfizer | Fremgangsmaate for konsentrering av vandige pseudoplastiske loesninger. |
| US4420398A (en) * | 1981-08-13 | 1983-12-13 | American National Red Cross | Filteration method for cell produced antiviral substances |
| US4435289A (en) * | 1981-12-23 | 1984-03-06 | Romicon, Inc. | Series ultrafiltration with pressurized permeate |
| EP0112510A1 (fr) * | 1982-11-30 | 1984-07-04 | "Continental Belro" | Procédé et dispositif pour régler la concentration de matières déterminées dans un liquide |
| JPH0669530B2 (ja) * | 1983-03-10 | 1994-09-07 | シー.ピー.シー.エンジニアリング コーポレイション | クロスフロ−濾過システムの流束率を向上せしめる方法並びに装置 |
| JPS6135803A (ja) * | 1984-07-26 | 1986-02-20 | Shin Etsu Chem Co Ltd | 複合中空糸 |
| US4879040A (en) * | 1984-11-15 | 1989-11-07 | Baxter International Inc. | Adaptive filter concentrate flow control system and method |
| US4874516A (en) * | 1984-12-29 | 1989-10-17 | Ngk Insulators, Ltd. | A ceramic filter for semi-ultrafiltration |
| JPS61283305A (ja) * | 1985-06-05 | 1986-12-13 | Ube Ind Ltd | 多孔質中空糸膜 |
| JPS621404A (ja) * | 1985-06-27 | 1987-01-07 | Mitsubishi Rayon Co Ltd | 多層複合中空繊維状膜及びその製造法 |
| US4741829A (en) * | 1985-06-27 | 1988-05-03 | Mitsubishi Rayon Co., Ltd. | Composite hollow fibers and method of making same |
| GB8600582D0 (en) * | 1986-01-10 | 1986-02-19 | Ca Minister Nat Defence | Purifying biological materials |
| US4789482A (en) * | 1986-02-10 | 1988-12-06 | Millipore Corporation | Method for separating liquid compositions on the basis of molecular weight |
| US4828705A (en) * | 1986-10-31 | 1989-05-09 | Kingston Technologies, Inc. | Pressure-dependent anisotropic-transport membrane system |
| US4789489A (en) * | 1988-02-26 | 1988-12-06 | Buckman Laboratories International, Inc. | Method for the control of mollusks |
| GB8812217D0 (en) * | 1988-05-24 | 1988-06-29 | Alcan Int Ltd | Composite membranes |
| EP0692303B1 (en) * | 1988-05-27 | 1999-01-27 | Ngk Insulators, Ltd. | Process for the production of an inorganic porous composite membrane |
| US5256294A (en) * | 1990-09-17 | 1993-10-26 | Genentech, Inc. | Tangential flow filtration process and apparatus |
-
1990
- 1990-09-17 US US07/583,886 patent/US5256294A/en not_active Expired - Lifetime
-
1991
- 1991-09-11 JP JP51568391A patent/JP3828143B2/ja not_active Expired - Lifetime
- 1991-09-11 ES ES91917291T patent/ES2072017T3/es not_active Expired - Lifetime
- 1991-09-11 CA CA002089663A patent/CA2089663C/en not_active Expired - Lifetime
- 1991-09-11 AT AT91917291T patent/ATE119063T1/de not_active IP Right Cessation
- 1991-09-11 DE DE69107855T patent/DE69107855T2/de not_active Expired - Lifetime
- 1991-09-11 DK DK91917291.6T patent/DK0552192T3/da active
- 1991-09-11 WO PCT/US1991/006553 patent/WO1992004970A1/en not_active Ceased
- 1991-09-11 EP EP91917291A patent/EP0552192B1/en not_active Expired - Lifetime
-
1994
- 1994-07-06 US US08/271,223 patent/US5490937A/en not_active Expired - Lifetime
-
1996
- 1996-02-28 LV LVP-96-59A patent/LV11283B/en unknown
-
2003
- 2003-05-30 JP JP2003156060A patent/JP2003334425A/ja not_active Withdrawn
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001000842A (ja) * | 1998-05-22 | 2001-01-09 | Daicel Chem Ind Ltd | 病原性原虫濃縮用モジュールおよび濃縮方法 |
| JP2003503041A (ja) * | 1999-06-25 | 2003-01-28 | アメリカン・サイアナミド・カンパニー | 内在性膜タンパク質の抽出 |
| JP2008514237A (ja) * | 2004-09-30 | 2008-05-08 | バイヤー ヘルスケア エルエルシー | 生体分子の一貫連続製造のための装置及び方法 |
| JP2012213772A (ja) * | 2004-09-30 | 2012-11-08 | Bayer Healthcare Llc | 生体分子の一貫連続製造のための装置及び方法 |
| US9045725B2 (en) | 2004-09-30 | 2015-06-02 | Bayer Healthcare Llc | Devices and methods for integrated continuous manufacturing of biological molecules |
| US9133433B2 (en) | 2004-09-30 | 2015-09-15 | Bayer Healthcare Llc | Devices and methods for integrated continuous manufacturing of biological molecules |
| JP2022524915A (ja) * | 2019-01-25 | 2022-05-11 | ベクトン・ディキンソン・アンド・カンパニー | 生体サンプルから構成成分を選択的に抽出する方法および機器 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2089663C (en) | 2002-05-28 |
| WO1992004970A1 (en) | 1992-04-02 |
| EP0552192A1 (en) | 1993-07-28 |
| EP0552192B1 (en) | 1995-03-01 |
| JP2003334425A (ja) | 2003-11-25 |
| ATE119063T1 (de) | 1995-03-15 |
| LV11283A (lv) | 1996-06-20 |
| LV11283B (en) | 1996-12-20 |
| US5256294A (en) | 1993-10-26 |
| US5490937A (en) | 1996-02-13 |
| DE69107855T2 (de) | 1995-09-07 |
| JP3828143B2 (ja) | 2006-10-04 |
| ES2072017T3 (es) | 1995-07-01 |
| DK0552192T3 (da) | 1995-07-17 |
| DE69107855D1 (de) | 1995-04-06 |
| CA2089663A1 (en) | 1992-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH06500730A (ja) | 改良された接線フロー濾過法および装置 | |
| Blatt et al. | Solute polarization and cake formation in membrane ultrafiltration: causes, consequences, and control techniques | |
| US12128359B2 (en) | Continuous diafiltration by means of tank cycling | |
| Michaels et al. | Ultrafiltration | |
| US9133433B2 (en) | Devices and methods for integrated continuous manufacturing of biological molecules | |
| JP2003519005A (ja) | クロスフロー濾過装置 | |
| Schwartz et al. | Introduction to tangential flow filtration for laboratory and process development applications | |
| Feins et al. | Highly selective membranes in protein ultrafiltration | |
| Fernandez et al. | Cross flow filtration of RNA extracts by hollow fiber membrane | |
| US4347138A (en) | Method of separating serum albumin and gamma-globulin from each other | |
| JPS59116223A (ja) | 膜によるタンパク質混合物の分画分離の方法 | |
| CN111318077A (zh) | 一种复用对流色谱系统及其用于纯化蛋白的方法 | |
| KR20240038924A (ko) | 미소 유용 물질의 분리 정제 방법과 분리 정제 장치 | |
| Kumpalume et al. | Chromatography: the high-resolution technique for protein separation | |
| Ho | Membranes for bioseparations | |
| CN209362021U (zh) | 一种复用对流色谱系统 | |
| Bell et al. | Membrane separation processes | |
| EP4166223A1 (en) | Separation system and method for separating and purifying a target component | |
| Belfort et al. | Biotechnology Processes: Membrane Materials, Modules and Process Design | |
| JPH06102136B2 (ja) | クロスフロ−型精密濾過における逆洗方法 | |
| Sartorius | Membranes for Protein Isolation and Purification | |
| Zydney | Membrane bioseparations | |
| JPH04150930A (ja) | クロスフロー濾過システム | |
| Ng et al. | Tangential flow cell separation from mammalian cell culture | |
| MICHAELS et al. | of Solute A from Solute B by ultrafiltration through a membrane permeable to A but not to B (or vice versa); and (4) analysis of |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20041202 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050720 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050805 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060523 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060706 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090714 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100714 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110714 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110714 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120714 Year of fee payment: 6 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120714 Year of fee payment: 6 |